We are live on ! Find out more
MXCT icon

MaxCyte

114 hedge funds and large institutions have $269M invested in MaxCyte in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 50 increasing their positions, 38 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 38

1.14% more ownership

Funds ownership: 64.22%65.37% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

4% less capital invested

Capital invested by funds: $281M → $269M (-$12.3M)

7% less funds holding

Funds holding: 123114 (-9)

43% less call options, than puts

Call options by funds: $8K | Put options by funds: $14K

47% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 17

Holders
114
Holders Change
-9
Holders Change %
-7.32%
% of All Funds
1.65%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
9
Increased
50
Reduced
38
Closed
17
Calls
$8K
Puts
$14K
Net Calls
-$6K
Net Calls Change
-$14K
Name Holding Trade Value Shares
Change
Change in
Stake
Creative Planning
76
Creative Planning
Kansas
$84K +$92.2K +21,440 New
SG Americas Securities
77
SG Americas Securities
New York
$81K -$48.2K -11,194 -35%
Citadel Advisors
78
Citadel Advisors
Florida
$75.8K -$157K -36,561 -65%
PNC Financial Services Group
79
PNC Financial Services Group
Pennsylvania
$75.6K +$56.1K +13,032 +208%
HSBC Holdings
80
HSBC Holdings
United Kingdom
$74.8K -$73.5K -17,086 -48%
ProShare Advisors
81
ProShare Advisors
Maryland
$71.2K -$20.7K -4,809 -21%
Susquehanna International Group
82
Susquehanna International Group
Pennsylvania
$65.2K -$97.6K -22,680 -58%
GPGA
83
Grandeur Peak Global Advisors
Utah
$65K -$1.01M -234,155 -93%
Verition Fund Management
84
Verition Fund Management
Connecticut
$59.9K +$65.8K +15,290 New
Envestnet Asset Management
85
Envestnet Asset Management
Illinois
$59.7K -$5.58K -1,296 -8%
Principal Financial Group
86
Principal Financial Group
Iowa
$57.7K -$50.2K -11,660 -44%
Pictet Asset Management
87
Pictet Asset Management
Switzerland
$57K
AQR Capital Management
88
AQR Capital Management
Connecticut
$52.9K -$8.2K -1,906 -12%
TRCT
89
Tower Research Capital (TRC)
New York
$51.3K +$48.8K +11,335 +651%
MC
90
Moors & Cabot
Massachusetts
$50.5K +$1.52K +353 +3%
CUAMC
91
China Universal Asset Management Company
China
$48.1K -$32.7K -7,602 -38%
Nisa Investment Advisors
92
Nisa Investment Advisors
Missouri
$46.9K +$125 +29 +0.2%
Victory Capital Management
93
Victory Capital Management
Texas
$46.6K -$495 -115 -1%
AIP
94
Ameritas Investment Partners
Nebraska
$40.2K +$12.2K +2,833 +38%
Royal Bank of Canada
95
Royal Bank of Canada
Ontario, Canada
$39K +$23.9K +5,558 +130%
BBHC
96
Brown Brothers Harriman & Co
New York
$24.5K
Federated Hermes
97
Federated Hermes
Pennsylvania
$22.1K -$4.79K -1,114 -17%
CAM
98
Close Asset Management
United Kingdom
$15K
AB
99
Amalgamated Bank
New York
$13K
Mirae Asset Global Investments
100
Mirae Asset Global Investments
South Korea
$12.5K -$169K -39,351 -93%

MXCT Hedge Fund Activity: Q2 2024 in Review

114 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q2 2024, worth a combined $269M — down 4.4% from $281M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of MXCT and 9 opened new positions — a net loss of 8 holders — while 38 trimmed existing stakes and 50 added.

The largest buyer was Morgan Stanley, adding an estimated $4.82M. The largest seller was Massachusetts Financial Services, cutting an estimated $8.71M.

  • 114 institutional investors held MaxCyte (MXCT) as of Q2 2024, down from 123 in Q1 2024.
  • Funds reported $269M of MaxCyte stock for Q2 2024, down 4.4% quarter-over-quarter.
  • 9 funds opened new MaxCyte positions in Q2 2024 and 17 closed out, a net change of -8 holders.
  • The largest MaxCyte buyer in Q2 2024 was Morgan Stanley, an estimated $4.82M added.
  • The largest MaxCyte seller in Q2 2024 was Massachusetts Financial Services, an estimated $8.71M sold.

Based on aggregated 13F filings for Q2 2024.